764
Helvetica Chimica Acta – Vol. 95 (2012)
of 4. After 30 min, MeI (0.14 g, 1.0 mmol) was added, and then the temp. was raised to r.t. over 30 min.
The resulting mixture was worked up as described for the preparation of 4, and the residue was purified
by CC (SiO2) to give 5a (0.13 g, 58%). Yellow oil. Rf (AcOEt/hexane 1:20) 0.36. IR (neat): 1610, 1473,
1434. 1H-NMR (400 MHz, CDCl3): 2.78 (s, 3 H); 7.23 (ddd, J ¼ 7.8, 7.3, 1.0, 1 H); 7.41 (ddd, J ¼ 8.3, 7.4, 1.0,
1 H); 7.79 (d, J ¼ 7.8, 1 H); 7.89 (d, J ¼ 8.3, 1 H). 13C-NMR (100 MHz, CDCl3): 16.74; 122.78; 124.15;
124.24; 126.17; 137.98; 154.78; 169.70.
2-(Ethylsulfanyl)benzoselenazole (5b). Yellow oil. Rf (AcOEt/hexane 1:20) 0.54. IR (neat): 1624,
1474, 1436. 1H-NMR (400 MHz, CDCl3): 1.49 (t, J ¼ 7.3, 3 H); 3.34 (q, J ¼ 7.3, 2 H); 7.21 (ddd, J ¼ 7.8, 7.3,
1.0, 1 H); 7.40 (ddd, J ¼ 7.8, 7.3, 1.0, 1 H); 7.78 (d, J ¼ 7.8, 1 H); 7.88 (d, J ¼ 7.8, 1 H). 13C-NMR (100 MHz,
CDCl3): 14.44; 28.61; 122.83; 124.17; 124.23; 126.10; 138.02; 154.75; 168.63. MS: 243 (100, Mþ). Anal.
calc. for C9H9NSSe (242.20): C 44.63, H 3.75, N 5.78; found: C 44.72, H 3.70, N 5.71.
2-[(Prop-2-en-1-yl)sulfanyl]benzoselenazole (5c). Yellow oil. Rf (AcOEt/hexane 1:5) 0.41. IR
(neat): 1634, 1473, 1450. 1H-NMR (500 MHz, CDCl3): 3.99 (dt, J ¼ 6.9, 1.1, 2 H); 5.22 (dd, J ¼ 10.3, 1.1,
1 H); 5.40 (dd, J ¼ 13.2, 1.1, 1 H); 5.99 – 6.08 (m, 1 H); 7.22 (ddd, J ¼ 8.0, 7.4, 1.1, 1 H); 7.40 (ddd, J ¼ 8.0,
7.4, 1.1, 1 H); 7.78 (dd, J ¼ 8.0, 1.1, 1 H); 7.88 (dd, J ¼ 8.0, 1.1, 1 H). 13C-NMR (125 MHz, CDCl3): 36.76;
119.20; 122.96; 124.25; 124.32; 126.13; 132.28; 138.24; 154.55; 167.64. MS: 255 (100, Mþ). Anal. calc. for
C10H9NSSe (254.21): C 47.25, H 3.57, N 5.51; found: C 47.08, H 3.66, N 5.38.
2-[(Phenylmethyl)sulfanyl]benzoselenazole (5d). Yellow oil. Rf (AcOEt/hexane 1:10) 0.61. IR
(neat): 1625, 1471, 1434. 1H-NMR (500 MHz, CDCl3): 4.59 (s, 2 H); 7.22 (dd, J ¼ 8.0, 7.4, 1 H); 7.28 (dd,
J ¼ 8.0, 7.4, 1 H); 7.33 (t, J ¼ 7.4, 2 H); 7.41 (t, J ¼ 7.4, 1 H); 7.46 (d, J ¼ 7.4, 2 H); 7.78 (d, J ¼ 8.0, 1 H); 7.91
(d, J ¼ 8.0, 1 H). 13C-NMR (125 MHz, CDCl3): 38.14; 122.94; 124.29; 124.34; 126.15; 127.72; 128.69;
129.16; 136.12; 138.28; 154.50; 167.79. MS: 305 (100, Mþ). Anal. calc. for C14H11NSSe (304.27): C 55.26, H
3.64, N 4.60; found: C 55.21, H 3.69, N 4.37.
5-Methyl-2-[(prop-2-en-1-yl)sulfanyl]benzoselenazole (5e). Yellow oil. Rf (AcOEt/hexane 1:5)
0.59. IR (neat): 1634, 1479, 1453. 1H-NMR (500 MHz, CDCl3): 2.42 (s, 3 H); 3.97 (d, J ¼ 6.9, 2 H); 5.21 (d,
J ¼ 9.9, 1 H); 5.39 (d, J ¼ 17.6, 1 H); 5.99 – 6.07 (m, 1 H); 7.20 (d, J ¼ 8.4, 1 H); 7.58 (s, 1 H); 7.76 (d, J ¼
8.4, 1 H). 13C-NMR (125 MHz, CDCl3): 21.26; 36.80; 119.12; 122.42; 124.23; 127.45; 132.36; 134.42;
138.36; 152.60; 166.19. MS: 269 (100, Mþ). Anal. calc. for C11H11NSSe (268.24): C 49.25, H 4.13, N 5.22;
found: C 49.07, H 4.15, N 5.13.
5-Chloro-2-(methylsulfanyl)benzoselenazole (5f). Pale-yellow solid. M.p. 81 – 838 (hexane/Et2O).
IR (KBr): 1628, 1477, 1444. 1H-NMR (500 MHz, CDCl3): 2.78 (s, 3 H); 7.36 (dd, J ¼ 8.8, 2.0, 1 H); 7.76 (d,
J ¼ 2.0, 1 H); 7.77 (d, J ¼ 8.8, 1 H). 13C-NMR (125 MHz, CDCl3): 16.72; 123.22; 123.86; 126.76; 129.88;
139.05; 153.36; 170.16. MS: 263 (100, Mþ). Anal. calc. for C8H6ClNSSe (262.62): C 36.59, H 2.30, N 5.33;
found: C 36.46, H 2.41, N 5.29.
S-(Benzoselenazol-2-yl) Thiobenzoate (6a). General Procedure. Compound 1a (0.21 g, 1.0 mmol) in
THF (4 ml) was treated with BuLi (1.0 mmol) and Se (79 mg, 1.0 mmol) in as described for the
preparation of 4. After 30 min, BzCl (0.14 g, 1.0 mmol) was added, and stirring was continued for an
additional 5 min. The resulting mixture was worked up as described for the preparation of 4, and the
residue was purified by CC (SiO2; AcOEt/hexane 1:10) to give 6a (0.18 g, 55%). Yellow solid. M.p. 120 –
1238 (Et2O/THF). IR (KBr): 1658, 1620, 1480, 1426. 1H-NMR (400 MHz, CDCl3): 7.37 (ddd, J ¼ 7.8, 7.3,
1.0, 1 H); 7.50 (ddd, J ¼ 7.8, 7.3, 1.0, 1 H); 7.57 (t, J ¼ 7.3, 2 H); 7.70 (tt, J ¼ 7.3, 1.4, 1 H); 8.00 (dd, J ¼ 7.8,
1.0, 1 H); 8.06 (dd, J ¼ 7.8, 1.0, 1 H); 8.08 (dd, J ¼ 7.3, 1.4, 2 H). 13C-NMR (100 MHz, CDCl3): 123.63;
125.19; 126.59; 127.51; 129.02; 129.65; 129.72; 134.76; 135.48; 149.74; 160.67; 187.32. MS: 319 (8.6, Mþ),
105 (100). Anal. calc. for C14H9NOSSe (318.25): C 52.84, H 2.85, N 4.40; found: C 52.60, H 2.95, N 4.34.
S-(Benzoselenazol-2-yl) 3-Methylthiobenzoate (6b). Pale-yellow solid. M.p. 111 – 1138 (hexane/
CHCl3). IR (KBr): 1657, 1602, 1480, 1422. 1H-NMR (400 MHz, CDCl3): 2.47 (s, 3 H); 7.37 (ddd, J ¼ 7.8,
7.3, 1.0, 1 H); 7.42 – 7.51 (m, 3 H); 7.87 – 7.88 (m, 2 H); 8.00 (d, J ¼ 7.8, 1 H); 8.06 (d, J ¼ 7.8, 1 H).
13C-NMR (100 MHz, CDCl3): 21.35; 124.01; 124.10; 124.86; 125.21; 126.31; 128.01; 129.04; 135.57; 135.59;
136.94; 139.23; 152.01; 160.88; 187.62. MS: 333 (8.5, Mþ), 119 (100). Anal. calc. for C15H11NOSSe
(332.28): C 54.22, H 3.34, N 4.22; found: C 54.06, H 3.62, N 4.16.
S-(Benzoselenazol-2-yl) Thiopropanoate (6c). White solid. M.p. 52 – 568 (hexane/Et2O). IR (KBr):
1702, 1460, 1429. 1H-NMR (500 MHz, CDCl3): 1.33 (t, J ¼ 7.4, 3 H); 2.86 (q, J ¼ 7.4, 2 H); 7.34 (dd, J ¼ 8.0,
7.4, 1 H); 7.47 (dd, J ¼ 8.0, 7.4, 1 H); 7.96 (d, J ¼ 8.0, 1 H); 8.02 (d, J ¼ 8.0, 1 H). 13C-NMR (100 MHz,